Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Perspective Therapeutics, Inc.

NYSE: CATX · Life Sciences · 14 alerts · CIK 728387

Perspective Therapeutics, Inc. stories on ALFA USA NewsRead the news →
Share price
$0.9238Close, Nov 16
Market cap
$112M
Shares outstanding
120.76MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Perspective Therapeutics, Inc. filings on SEC EDGAR ↗

8:30 AM ET Form 4
Insider Buying

Perspective Therapeutics Director Frank Morich Buys $14K of Stock

Frank Morich, Director, bought 15,000 shares of Perspective Therapeutics, Inc. at $0.9364 a share, worth $14K in total on Nov 16, 2026. Shares held after the trade: 30,000 (+100.0%).

Value
$14K
Shares
15,000
Price
$0.9364
Role
Director
Holding change
+100.0%
Trade date
Nov 16, 2026
8:30 AM ET Form 4
Insider Buying

Perspective Therapeutics Director Robert F. Williamson III Buys $15.6K of Stock

Robert F. Williamson III, Director, bought 18,609 shares of Perspective Therapeutics, Inc. at $0.84 a share, worth $15.6K in total on Nov 12, 2026. Shares held after the trade: 28,473 (+188.7%).

Value
$15.6K
Shares
18,609
Price
$0.8400
Role
Director
Holding change
+188.7%
Trade date
Nov 12, 2026
8:30 AM ET Form 4
Insider Buying

Perspective Therapeutics Director Frank Morich Buys $15K of Stock

Frank Morich, Director, bought 15,000 shares of Perspective Therapeutics, Inc. at $0.9971 a share, worth $15K in total on Nov 12, 2026. Shares held after the trade: 15,000.

Value
$15K
Shares
15,000
Price
$0.9971
Role
Director
Trade date
Nov 12, 2026
8:30 AM ET Form 4
Insider Buying

Perspective Therapeutics Director Lori A. Woods Buys $20K of Stock

Lori A. Woods, Director, bought 23,750 shares of Perspective Therapeutics, Inc. at $0.8438 a share, worth $20K in total on Nov 12, 2026. Shares held after the trade: 28,557 (+494.1%).

Value
$20K
Shares
23,750
Price
$0.8438
Role
Director
Holding change
+494.1%
Trade date
Nov 12, 2026
8:30 AM ET Form 4
Insider Buying

Perspective Therapeutics CMO Markus Puhlmann Buys $29.6K of Stock

Markus Puhlmann, CMO, bought 35,000 shares of Perspective Therapeutics, Inc. at $0.8447 a share, worth $29.6K in total on Nov 12, 2026. Shares held after the trade: 178,542 (+24.4%).

Value
$29.6K
Shares
35,000
Price
$0.8447
Role
CMO
Holding change
+24.4%
Trade date
Nov 12, 2026
8:30 AM ET Form 4
Insider Buying

Perspective Therapeutics CEO Johan M. Spoor Buys $37.9K of Stock

Johan M. Spoor, CEO, bought 47,000 shares of Perspective Therapeutics, Inc. at $0.8073 a share, worth $37.9K in total on Nov 11, 2026. Shares held after the trade: 106,383 (+79.1%).

Value
$37.9K
Shares
47,000
Price
$0.8073
Role
CEO
Holding change
+79.1%
Trade date
Nov 11, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.